e-Drug3D

1423

NORELGESTROMIN


INN
NORELGESTROMIN

(is an active metabolite)

cas 53016-31-2
CLASS

GENITO
CONTRACEPTIVE

ROUTE (list)

TRANSDERMAL

ATC code

G03AA13

PK parameters

Tmax 2 HOUR
PPB 97 PERCENT
t1/2 32.1 HOUR

Target

TARGET PROGESTERONE RECEPTOR

DrugCentral

Progesterone receptor UNIPROT P06401 PGR

Download SDF file 18,19-Dinorpregn-4-en-20-yn-3-one, 13-ethyl-17-hydroxy-, oxime, (17.alpha.)-

Formula:
C21H29NO2

Calculated chemical properties:

MW 327.45
NB_atoms 24
XLogP 4.14
PSA 50.695
NB_HD 2
NB_HA 3
fsp3 0.76
Lipinski(0=no;1=yes) 1

FDA
NDA 021180 (label) INN (ETHINYL ESTRADIOL ; NORELGESTROMIN) ORTHO EVRA (JANSSEN PHARMS) APPROVAL= AP YEAR= 2001 DISCONTINUED
NDA 200910 (pdf not found) INN (ETHINYL ESTRADIOL ; NORELGESTROMIN) XULANE (MYLAN TECHNOLOGIES) APPROVAL= AP YEAR= 2014
NDA 213950 (pdf not found) INN (ETHINYL ESTRADIOL ; NORELGESTROMIN) ETHINYL ESTRADIOL AND NORELGESTROMIN (AMNEAL) APPROVAL= AP YEAR= 2021
NDA 213977 (pdf not found) INN (ETHINYL ESTRADIOL ; NORELGESTROMIN) ONSURA (TEVA PHARMS USA) APPROVAL= AP YEAR= 2021
NDA 214594 (pdf not found) INN (ETHINYL ESTRADIOL ; NORELGESTROMIN) ETHINYL ESTRADIOL AND NORELGESTROMIN (ZYDUS NOVELTECH INC) APPROVAL= AP YEAR= 2023

Other links:

PubChem
ChemicalProbes

U.S. repository of Clinical Trials

VigiAccess
SIDER side effects

ChemSynthesis
Patent@SureChEMBL